Vol 4 (September 30, 2021): Precision Cancer Medicine

Massive hyper-progression during anti-PD-1 immunotherapy in a young patient with metastatic mucinous adenocarcinoma of the right colon: a case report and literature review

Women treating lung cancer: a narrative review

Next-generation sequencing using liquid biopsy in the care of patients with ALK-rearranged non-small cell lung cancer: a focus on lorlatinib

Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches—a narrative review

Sex-based heterogeneity in non-small cell lung cancer (NSCLC) and response to immune checkpoint inhibitors (ICIs): a narrative review

ROS1 non-small cell lung cancer patients treatment approach

A narrative review of biomarkers in advanced triple negative breast cancer

Non-coding RNA regulatory networks in mesothelioma: a narrative review of their implication in innate immune signaling pathways

A narrative review of predictive and prognostic biomarkers in skin tumors

Malignant peritoneal mesothelioma: a narrative review of the rationale for and results of treatment using ultraradical local-regional strategy